Due to the inhibitory effect of quercetin on VEGF/Akt signaling, and the potential of VEGF/VEGFR as therapeutic target in AML, we hypothesized that quercetin may exert anti-cancer effect via VEGF/Akt signaling in AML. The gene discussed is AKT1; the disease is cancer.